The pharmaceutical industry is as demanding as any other industry, if not more. Advancements in research and development are constant demands, significantly changing the industry’s paradigm in the past year. Here are some trends that shook the pharmaceutical research world in 2018, rightfully dictating its future.

The sudden march of technology giants. Amazon and Google made their presence known in the pharmaceutical realm this year by purchasing online pharmacy PillPack, and instituting the Google Life Sciences’ revamp, respectively. With the data-gathering and -processing capabilities of these companies, the development of many other studies gained new heights. These tech giants are re-shaping procedures for clinical trials, thus challenging traditional companies to keep up with the race.
Bioprinting. Cellink, a start-up, became the first company in the world to offer 3D-printed bioink— a liquid that allows the growth of human cells. This year, the company has started to produce bioprints of other parts of the body, such as noses and ears meant for cosmetic and drug trials.
An award-winning entrepreneur and business leader, Steven Scansaroli has behind him a career record of defining and implementing strategies driving revenue, profit, and competitive market advantages in startups, turnarounds, and Fortune 500 companies. He has had more than 20 years of industry experience in medical devices, healthcare, chemicals, and pharmaceuticals. For more articles like this, visit this page.